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Abstract 
Background: Previous studies reported that Palladium (Pd)(II) drug compounds showed significant anti-tumor 
activity in comparison with cis-platin. Materials and Methods: In this study, we investigated the biological 
evaluations of a designed Pd (II) complexes (bi pyridine ethyl dithiocarbamate palladium II nitrate) via its anti-
proliferative effects on the alterations in the function and structure of human hemoglobin (Hb) at different 
temperatures of 25 and 37°. Also for further investigation, multi-spectroscopic methods such as fluorescence and the 
far-UV circular dichroism (CD) with hemoglobin target were assessed. Results: Fluorescence data showed the pure 
ability of Pd(II) complex to quench the intrinsic fluorescence of Hb. The binding constant, number of binding sites, 
and thermodynamic parameters at two temperatures were assessed and the results demonstrated the major possibility 
of occurring electrostatic and hydrophobic interactions in the Pd (II) complex–Hb interaction. For evaluating the 
change of secondary structure of Hb upon interaction with various concentrations of complex, far-UV CD spectra 
was applied and it was observed that in high dose of complex, significant changes occurred which is indicative of 
some side effects in overdosing of this complex. Conclusion: Our results suggested that using palladium complex as 
an anticancer agent might cause some disorders in structure and function of Hb as well as improve understanding of 
the side effects of newly designed metal anticancer drugs. 
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After cardiovascular disorders, cancer is a 
serious cause of human death all over the world. One 
of best known method for cancer treatment is 
chemotherapy that uses metal compounds as anti-
tumor agents. The use of metal-based complexes as 
therapeutic drugs dates back to many years ago (1). 
By easily losing electrons and making cationic form, 
the attraction of these opposing charges leads to a 
general tendency for metal ions to bind to and 
interact with biological molecules (2). But serious 
side effects have become obstacles in treatment when 
current compounds with anticancer activity are used, 
therefore it is necessary to search for new potential 
antitumor substances to improve treatment efficacy 
with smaller doses and less toxic drugs. The 
development of drugs that selectively eliminate cancer 
cells without harming normal ones also remains a 
considerable challenge (3). Based on the previous 
studies, it is proved that Pd (II) complexes have 
antitumor activity and cytotoxic effects on tumor cells 
(4). Palladium (and platinum) salts were shown to 
possess both histamine-releasing and histamine 
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binding properties. The latter effect might be one of 
the possible mechanisms of the antitumor effect of 
palladium as well as platinum salts, since histamine 
binding in tumor cells is suggested to suppress their 
proliferation (5). Many investigations demonstrate 
that hydrolysis of leaving ligands in palladium 
complexes is too rapid, 100 times faster than their 
related platinum analogues (2). Pt (II) complexes 
bind the thiol-containing enzymes of the renal and 
cause serious side effects on kidney, but palladium 
complexes with dithiol structural group have less 
kidney toxicity (6). 
Hemoglobin is the most important oxygen 
transporter in red blood cells which carries oxygen 
from the lungs to the tissues in blood (7). This carrier 
protein consists of from two α-chains and two β-
chains with141 (15126.1 Da) and 146 (15867.2 Da) 
amino acids, respectively (8). Some non-helical 
segments separate the α and β subunits which are 
made up by seven and eight helices, respectively (9). 
Also, Hb is classified as metallo-proteins for its 
heme-containing structure which join to each chain 
by a non-covalent interaction (10). Besides oxygen, 
hemoglobin is involved in the transport of other 
gases such as carbon dioxide (about 20-25% of the 
total). Hb also carries some regulatory molecules 
such as nitric oxide and heavy metal-based drugs for 
remedy aims (7). 
These results lead us to investigate in more 
detail the reactivity of these derivatives towards vital 
proteins. In this study, a novel anticancer Pd(II) 
complex (bi pyridine ethyl dithiocarbamate 
palladium II nitrate) (Fig.1) was designed and 
binding properties and effects of this novel Pd(II) 
compounds on the structure and function of 
hemoglobin by different spectroscopic techniques 
(fluorescence and far UV circular dichroism (CD)) 
was investigated. 
Methods 
For extracting and purifying human Hb, 
previous well-established methods were applied. All 
other materials and reagents were of analytical grades, 
and solutions were made in double-distilled water. 
Synthesis of Pd(II) complex. The solution of 1 
mmol [Pd(phen)(H2O)2](NO3)2 in 20 ml was mixed 
with amyl-glycine hydrochloride (1 mmol) and 
NaHCO3 (0.17 gr, 2 mmol) dissolved in 9 ml distilled 
water at 50 ºC for 2 hours in dark. Then, light yellow 
solution was filtrated and concentrated to 15 ml at 35 
ºC. The trace amount of turbidity formed was filtered 
and the clear yellow filtrate was further concentrated 
to about 5 ml at 35 ºC (very fine needle crystals of the 
complex not suitable for X-Ray crystallography were 
obtained by slow evaporation of this solution). The 
yellow crystals was filtered and washed with little 
amount of chilled double distilled water and then dried 
in vacuum oven. 
  [Pd(phen)(amylgly)]NO3 (M.W. =493.63 
g/mol): The yield of the complex was 222 mg, %45; 
Elementary analysis calculated (found %) for 
C19H23N4O5Pd: C, 46.12 (46.16); H, 4.66 (4.8); N, 
11.34 (11.22); IR (cm−1, solid): 3432 (w), 3051 (w), 
2929 (w), 1625 (s), 1591, (s), 1511 (s) 1426 (s), 1354 
(d), 1229 (s), 1139 (s), 1033 (s), 939 (s), 837 (s), 710 
(s), 645 (s), 534 (s); 1H NMR (300 MHz, DMSO-d6, δ 
in ppm): 0.830 (t, 3H), 1.239 (m, 2H), 1.346 (m, 2H), 
1.376 (m, 2H), 2.680 (m, 2H), 3.518 and 4.203 (d, 
2H), 7.84 (s, NH), Aromatic protons: 9.340 (m, 2H), 
9.130 (m, 2H), 8.750 (m, 2H), 8.100 (m, 2H). 
0 (m, 2H), 8.750 (m, 2H), 8.100 (m, 2H). 
Fluorescence measurements. For monitoring 
changes in intrinsic fluorescence intensity, Cary 
Eclipse Spectrofluorimeter (Varian Co., Australia) 
were carried out in the absence and presence of 
various concentrations of the Pd(II) complex (0, 3, 5, 
7, 9, 11, 13, 15, 17 and 19 M). The wavelength of 
excitation was established at 290 nm and emission 
spectra for all of the samples were recorded in the 
range of 300-500 nm at two temperatures of 25 and 
37oC. All measurements were done by using a 
fluorescence cuvette with a 1 cm path length with 20 
μM. Concentration of Hb. 
Circular dichroism (CD) measurements. 
Alteration in CD spectra of Hb protein in the absence 
 
Figure 1. The molecular structure of Pd(II) complex. 
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and presence of various concentrations of a novel 
Pd(II) complexes (0, 2, 4 and 6 M) were analyzed 
on an Aviv Spectropolarimeter (model 215 Proterion 
Corp., USA) in far-UV region (190–260 nm) using 1 
mm path length at two temperatures of 25 and 37°C. 
The obtained data were given in molar ellipticity [θ] 
(deg cm2 dmol-1) based on a mean amino acid 
residue weight of 114 (MRW). The molar ellipticity 
at wavelength λ was fixed as [θ]λ= (100 × MRW × 
θobs/cl), where θobs is the monitored ellipticity in 
degrees at λ nm, c is the concentration of protein in 
mg ml-1, and l is the length of the light path in 
centimeters. For clarifying the secondary structure of 
the protein CD software of CDNN was applied based 
on the statistical method (11). 
Results 
Fluorescence Studies. One of the most 
powerful technique for investigating molecular 
interactions especially proteins is fluorescence 
spectroscopy (12). Since the intrinsic fluorescence of 
indol chromophores in Trp residues is extremely 
sensitive to their microenvironment, by studying the 
conformational alterations of proteins containing 
internal fluorophores, such as Trp residues, this 
method provides very useful information during the 
binding of ligands (13). Intrinsic fluorescence of Trp 
residue of Hb in the absence and presence of the 
different concentrations the Pd(II) complex were 
useful data for determining the mechanisms of drug 
binding to protein and its dynamic and structural 
functions (14). In tetrameric structure of Hb there are 
six Trp residues at all. Each αβ dimmer of Hb 
tetramer contains three Trp residues (α-14Trp, β-15 
Trp and β-37 Trp) (15). The responsible intrinsic 
fluorophore is β-37 Trp residue at the α1β2 interface. 
In this study, Hb solution was excited at 285 
nm and the emission spectra were recorded between 
300 and 450 nm at two temperatures of 25 and 37oC 
in the absence and presence of different 
concentrations of Pd(II) complex (Figure 2). As it is 
presented in Fig. 2 (only 25 oC is shown), the 
fluorescence intensity of Hb regularly decreased 
upon addition of Pd (II) complex. Since Fig. 2 
represents, quenching of Hb with an increasing 
palladium/Hb ratio, interaction of the drug complex 
with Hb was occurred and refold the 
microenvironment of Trp residue(s), and also protein 
native structure. 
For predicting binding mechanisms of a drug to 
a protein, assessing the intrinsic fluorescence 
quenching of the studied protein provides very useful 
data. These data can be gathered by the calculating the 
accessibility of quenchers to the fluorophore groups of 
proteins (12). Fluorescence quenching usually 
proceeds via dynamic quenching or static quenching 
(16). In dynamic quenching, diffusive collisions 
between the fluorophores and the quencher in the 
excited state is usually  occurred. Since it depends on 
diffusion effects, many of the coefficients and 
constants such as diffusion coefficients and 
bimolecular quenching constants increase with 
increasing temperatures. In contrast, the static 
mechanism shows different manner. In this 
mechanism, a ground-state complex between the 
fluorophores and the quencher is formed and therefore, 
a non-fluorescing complex is generated in static 
quenching which made a lower stability and the values 
of static quenching constants with higher temperature 
(17). 
For investigating the quenching mechanism of 
the Pd (II) interaction with Hb, quenching experiments 
were carried out. For fluorescence quenching, the 
well-known Stern–Volmer equation usually is used to 
determine the decrease in intensity (18): 
 = 1 +Ksv⦋Q⦌= 1+ kqτo⦋Q⦌           (1) 
where Fo and F are the fluorescence intensities 
in the absence and presence of quencher (Pd(II) 
complex) respectively, [Q] is the concentration of the 
 
Figure 2. Fluorescence titration curve of Hb (5µM) in the 
absence and presence of various concentrations of Pd(II) 
complex in NaCl solution (5 mM) at 25˚C. 
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quencher, Ksv is the Stern–Volmer quenching 
constant, kq is the quenching rate constant of protein, 
and τ0 is the average life time of the protein without 
any quencher (Pd(II) complex) (19).  
The experimental data were analyzed using 
Equation (1), and the results were presented in 
Figures 3 and Tables 1. The results of Fig. 3a and 
Table 1 show that the Stern–Volmer plot is linear and 
the values of Stern-Volmer quenching constants, 
KSV, is not increased by increasing the temperature, 
indicating the presence of static quenching of 
fluorescence in Hb in Pd(II) complex.  
 
Binding Studies. As mentioned above, 
fluorescence experiments demonstrate that Trp 
fluorescence quenching during Pd(II) interactions 
with Hb follows a static quenching type. Therefore, 
according to the literature, estimating the binding 
parameters of the Pd(II) complex to protein can be 
possible by following equation (18): 
  = log K + n log [Q]               (2) 
Where K is the binding constant and n is the 
binding number (18). Table 1 present the calculated 
values of n and K. According to Eq. (2), the binding 
number can be estimated from the slope of the static 
quenching plot of log [(F0-F)/F] versus log [Q] (18). 
All resulted data at different temperatures of 25 
and37oC for the drug complex are also summarized in 
Table 1. By concerning these Figure and Table, the 
value of n is close to 1 for the Pd (II) complex and 
hence there is one binding site in Hb structure for each 
of the Pd(II) complexes. Finally, concerning the tables 
and figures, estimated binding constants for the drug 
compounds at 25 and37 oC reveal that the complex 
formation between Pd(II) and Hb is affected by heat. 
In other words, there is an exothermic reaction in both 
reactions (Fig. 3b and Table 1).  
 
Determination of thermodynamic parameters. 
As mentioned above, a thermodynamic process is 
responsible for the formation of the complex. hence, 
dependency on heat was analyzed for better 
characterizing the forces acting between ligands and 
protein (20). Essentially, there are four types of non-
covalent interactions stabilizing ligand-protein 
connections: hydrophobic interactions, van der Waals 















25 0.210.001 1.40.07 0.25 1 0.3 -30.71 -22 6 -11.3 
37 0.230.0008 0.70.03 6.3 1 0.3 -40.70.2   
 
 
Figure 3a. Stern-Volmer plots of Pd(II) complex and Hb 
interaction in NaCl solution (5 mM) at different 
temperatures of 25 (●) and 37˚C (○). 
 
 
Figure 3b. The plot of log (F0-F/F) vs. log [Pd] resulted from 
fluorescence quenching data at different temperatures of 25 (●) and 
37˚C (○). 
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forces, hydrogen bonds and electrostatic forces (21). 
Enthalpy change (ΔHo) and entropy change (ΔSo) of 
binding reactions are two main criteria confirming 
binding modes in thermodynamic parameters (12). 
Using the van’t Hoff equation for estimating 
thermodynamic parameters is a common way for 
terms that the alteration in interaction enthalpy and 
entropy does not vary significantly over the 
temperature range studied (16).  
 
 lnK=                                 (3) 
 
where K is the binding constant obtained from 
Eq. (2) at the corresponding temperature (T), and R 
is the gas constant (22). Also, the free energy change 
(ΔG°) is determined from the following relationship 
(23). 
ΔG° = HT∆So=  RT ln K        (4) 
According to previous studies, (24) during protein 
association processes, the sign and magnitude of 
thermodynamic parameters with different individual 
types of interactions that may occurred, from which 
it can usually be concluded: (a) ΔH > 0 and ΔS> 0, 
hydrophobic forces; (b) ΔH < 0 and ΔS < 0, van der 
Waals forces and hydrogen bonds; (c) ΔH <0 and ΔS 
> 0, electrostatic interactions (25). The estimated 
values of thermodynamic parameters of the 
palladium complex are summarized in Table 1. In 
this manuscript, the negative sign for the values of 
the ΔG° for the Pd(II) complexe during interaction 
with Hb is indicative of spontaneous interactions 
(26). Also the negative values of ΔHo and the 
positive value of ΔSo for binding of complexes to Hb 
are usually taken as an evidence for electrostatic 
interactions (27). These kinds of interactions usually 
accompanied with surface hydrophobicity increase 
and may be confirmed that electrostatic and 
hydrophobic interaction might be responsible for the 
occurrence of interactions between the drug 
compound and Hb.  
CD Results. Another ideal technique for 
studying conformational changes in protein 
secondary and tertiary structures is Circular 
Dichroism (CD). Some experimental conditions such 
as ligand-protein binding can causes CD occurrence. 
To characterizing the secondary structure of proteins 
due to peptide bond absorption, the far-UV-CD 
spectra is a common way (28). In this study, the 
structural changes of Hb in the absence and presence 
of various concentrations of the Pd (II) complex at 
several temperatures of 25 and 37oC were recorded 
and are presented in Figs. 4 and 5. The contents of 
secondary structure elements in Hb in the absence and 
presence of various concentrations of the Pd (II) 
complex at different temperatures of 25 and 37oC 
were monitored and all resulted data are shown in 
tables 2 and 3. Changes in Hb secondary structure 
demonstrate the degree of structural stability. Protein 
structural stabilization in the presence of ligand is 
observed when an increase in β -sheet and α -helix 
contents and a decrease in random coil content occur. 
Conversely, decrease in protein structural stability is 
monitored by a decrease in b-sheet and a-helix 
contents and an increase in random coil content in the 
 
Figure 4. Far-UV CD spectra of Hb (10.2 µM) in the absence 
and the presence of different concentrations of Pt(II) complex 
93.3, 186.6, 266.6 µM (from down to up) in NaCl solution (5 




Figure 5. Far-UV CD spectra of Hb (10.2 µM) in the absence 
and the presence of different concentrations of Pt(II) complex 
93.3, 186.6, 266.6 µM (from down to up) in NaCl solution (5 
mM) at 37˚C. 
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presence of ligand (28). All resulted data summarized 
in Fig. 5 and Table 2-3. Concerning all these data 
imply that Pd (II) complexes /Hb interaction causes a 
decrease in protein stability.  
Discussion 
Fluorescence measurements implied that static 
quenching is dominated mechanism in the 
quenching. Furthermore, from the estimated 
thermodynamic parameters, there is one binding site 
for the drug compound in protein structure. ΔG°, 
ΔHo and ΔSo values were determined at four 
temperatures of 25 and 37°C for the drug compound 
and resulted data reveal that electrostatic and 
hydrophobic forces proceed interaction between the 
Pd(II) complex and Hb. Also, negative sign for the 
Gibbs free energy value during the binding the Pd 
(II) complex to protein was indicative of a 
spontaneous interaction. CD spectroscopy 
monitoring implied that the drug-protein interaction 
caused an alteration in α-helix contents of the 
hemoglobin at experimented temperatures and also 
significant changes in tertiary structure of the Hb. 
Conclusion 
The development of a sufficient Pd (II) 
anticancer compound involves particular requisites: 
stabilization by a strongly coordinated ligand coupled 
to an exact choice of leaving group(s), in order to 
ensure the in vivo structural integrity of the compound 
for a long enough period to enable it to perform its 
therapeutic action (29). These results provide useful 
information for designing effective anti-cancer 
compounds in order to find a trustworthy way for the 
treatment of cancer. 
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